Pergolizzi Joseph V, Magnusson Peter, LeQuang Jo Ann, Razmi Robin, Zampogna Gianpietro, Taylor Robert
NEMA Research, Inc., Naples, FL, USA.
Cardiology Research Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Pain Ther. 2020 Jun;9(1):97-111. doi: 10.1007/s40122-020-00153-9. Epub 2020 Feb 4.
The frequently prescribed drug class of statins have pleiotropic effects and have been implicated in neuropathic pain syndromes. This narrative review examines studies of statin-induced neuropathic pain which to date have been conducted only in animal models. However, the pathophysiology of diabetic neuropathy in humans may shed some light on the etiology of neuropathic pain. Statins have exhibited a paradoxical effect in that statins appear to reduce neuropathic pain in animals but have been associated with neuropathic pain in humans. While there are certain postulated mechanisms offering elucidation as to how statins might be associated with neuropathic pain, there is, as the American Heart Association stated, to date no definitive association between statins and neuropathic pain. Statins are important drugs that reduce cardiovascular risk factors and should be prescribed to appropriate patients with these risk factors but some of this population is also at elevated risk for neuropathic pain from other causes.
常用的他汀类药物具有多效性,并且与神经性疼痛综合征有关。这篇叙述性综述考察了迄今为止仅在动物模型中进行的他汀类药物诱发神经性疼痛的研究。然而,人类糖尿病性神经病变的病理生理学可能会为神经性疼痛的病因提供一些线索。他汀类药物表现出一种矛盾的效应,即他汀类药物似乎能减轻动物的神经性疼痛,但却与人类的神经性疼痛有关。虽然有某些假定的机制可以解释他汀类药物如何与神经性疼痛相关,但正如美国心脏协会所说,迄今为止他汀类药物与神经性疼痛之间尚无明确的关联。他汀类药物是降低心血管危险因素的重要药物,应该给有这些危险因素的合适患者开此类药物,但这部分人群中一些人因其他原因患神经性疼痛的风险也会升高。